Panic Disorder Market Size, Share, Trends, Growth, Report 2024-2032

According to a new report by Expert Market Research titled, “Panic Disorder Market Size, Share, Analysis, Report and Forecast 2024-2032″, The global panic disorder market has been experiencing remarkable growth, fueled by a growing awareness of mental health issues and advancements in treatment options. In 2023, the market size in the seven major markets reached USD 9.7 billion, and it’s projected to expand at a Compound Annual Growth Rate (CAGR) of 4.18% from 2024 to 2032, reaching USD 14 billion by the end of the forecast period. In this comprehensive guide, we’ll delve into the overview, dynamics, trends, segmentation, growth factors, recent developments, analysis, and key players of the panic disorder market.

Panic Disorder Market Overview

Panic disorder is a prevalent mental health condition characterized by recurrent, unexpected panic attacks. These episodes can be debilitating, leading to severe distress and impairing daily functioning. The market for panic disorder encompasses pharmaceuticals, therapies, and other interventions aimed at managing symptoms and improving patients’ quality of life.

Panic Disorder Market Dynamics

Several factors are driving the growth of the panic disorder market. Increased awareness and understanding of mental health issues have reduced the stigma surrounding panic disorder, prompting more individuals to seek diagnosis and treatment. Additionally, advancements in medical technology and pharmacology have led to the development of more effective therapies with fewer side effects, enhancing patient outcomes and satisfaction.

Panic Disorder Market Trends

External trends shaping the panic disorder market include the rise of telemedicine and digital health platforms, which offer convenient access to mental health services. Moreover, the integration of Artificial Intelligence (AI) and machine learning algorithms in diagnostic tools and treatment protocols is revolutionizing patient care by enabling personalized interventions tailored to individuals’ specific needs.

Get a Free Sample Report with a Table of Contents –

Panic Disorder Market Segmentation


  • This segment includes medications prescribed for the treatment of panic disorder, such as selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines.
  • SSRIs, such as sertraline and fluoxetine, are commonly prescribed as first-line pharmacotherapy due to their efficacy in reducing the frequency and severity of panic attacks.
  • Benzodiazepines, such as alprazolam and clonazepam, are often used for short-term management of acute symptoms but may carry a risk of dependence and tolerance.


  • Psychotherapy plays a crucial role in the treatment of panic disorder and can be delivered through various modalities, including cognitive-behavioral therapy (CBT), exposure therapy, and mindfulness-based interventions.
  • CBT is the most extensively studied and empirically supported psychotherapeutic approach for panic disorder, focusing on identifying and challenging maladaptive thought patterns and behaviors associated with panic attacks.

Lifestyle Interventions:

  • Lifestyle interventions encompass non-pharmacological approaches to managing panic disorder symptoms, such as stress management techniques, relaxation exercises, and dietary modifications.
  • These interventions aim to reduce stress levels, improve coping mechanisms, and promote overall well-being, thereby complementing pharmacological and psychotherapeutic treatments.

Digital Therapeutics:

  • Emerging technologies, such as smartphone applications and wearable devices, are increasingly being integrated into the management of panic disorder.
  • Digital therapeutics offer innovative tools for self-monitoring, symptom management, and therapeutic interventions, providing patients with convenient access to support resources and enhancing treatment adherence and engagement.

Panic Disorder Market Growth

The growth of the panic disorder market is propelled by various factors, including increasing awareness, expanding treatment options, and favorable regulatory environments. As mental health issues gain prominence on the global agenda, there’s a growing recognition of the prevalence and impact of panic disorder, driving demand for effective interventions. Advancements in medical technology and pharmacology have led to the development of innovative treatments with improved efficacy and tolerability, expanding the therapeutic options available to patients. Additionally, strategic investments in research and development, along with collaborations between industry stakeholders, are driving innovation and accelerating the pace of therapeutic advancements. With a projected Compound Annual Growth Rate (CAGR) of 4.18% from 2024 to 2032, the panic disorder market presents significant opportunities for growth and investment, as well as the potential to address unmet needs and improve outcomes for individuals living with this debilitating condition.

Recent Developments in the Panic Disorder Market

Recent developments in the panic disorder market have witnessed notable advancements in treatment options and supportive technologies. Pharmaceutical innovations, including the introduction of novel compounds with enhanced efficacy and safety profiles, have expanded the therapeutic arsenal available to healthcare providers and patients. Furthermore, the integration of digital therapeutics, such as smartphone applications and wearable devices, has revolutionized patient care by offering personalized interventions, remote monitoring, and real-time symptom management. Strategic partnerships and collaborations between pharmaceutical companies, research institutions, and technology firms have facilitated the development and commercialization of innovative solutions for panic disorder. These recent developments signify a paradigm shift in the management of panic disorder, emphasizing a holistic approach that combines pharmacotherapy, psychotherapy, and digital health interventions to optimize patient outcomes and improve quality of life.

Panic Disorder Market Analysis

The panic disorder market analysis offers a comprehensive understanding of the industry landscape, revealing key factors driving growth and investment opportunities. It encompasses various aspects, including market size, trends, and competitive dynamics. By examining the prevalence of panic disorder, emerging treatment modalities, and evolving patient preferences, analysts can identify strategic opportunities for pharmaceutical companies, healthcare providers, and investors. Additionally, the analysis delves into regulatory frameworks, reimbursement policies, and market entry barriers, providing insights into the market’s competitive dynamics. Through rigorous assessment of market trends, innovations, and competitor strategies, stakeholders can make informed decisions to capitalize on emerging opportunities and address challenges within the panic disorder market, ultimately driving sustainable growth and improving patient outcomes.

Competitor Analysis

Several key players dominate the panic disorder market, each contributing unique strengths and expertise to the industry. Among them are:

  • Teva Pharmaceutical Industries Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Mylan
  • AstraZeneca
  • Abbott
  • Baxter
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Recordati S.p.A.
  • Boehringer Ingelheim International GmbH.
  • Neurocrine Biosciences, Inc
  • Sanofi


What is panic disorder?

  • Panic disorder is a mental health condition characterized by recurrent panic attacks, which are sudden episodes of intense fear or discomfort.

What are the symptoms of panic disorder?

  • Symptoms of panic disorder may include palpitations, sweating, trembling, shortness of breath, chest pain, nausea, dizziness, and fear of losing control or dying.

How is panic disorder treated?

  • Treatment for panic disorder typically involves a combination of medication, such as SSRIs or benzodiazepines, and psychotherapy, such as CBT. Lifestyle interventions, including stress management techniques and relaxation exercises, may also be beneficial.

What are the key players in the panic disorder market?

  • Key players in the panic disorder market include pharmaceutical companies, such as Teva Pharmaceutical Industries Ltd, AstraZeneca, and Eli Lilly and Company, as well as biotechnology firms and digital health companies.